| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_527a713bfe931272bd799814ea7b0a13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8947c557f441b5be96967874cee0d8cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31ebfd5259a6c3f9e60cea5df0eebd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8a3f4f1de02572a1075b42e9cac42f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21d11442cefd0338a7ee4fa0bf477b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14aaefc355b81fc9804060ba131a2993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7ebd2ce5ef7e691bd44c48a88a2bfc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40 |
| filingDate |
2011-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d64f6933bc03cda6defd2453a07b738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3808e0ef645cba9a6795f1b4d7fb5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99bcee698d3b94cdf464b1665a92da92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5230529bcd0697e5bc9fc3adb9d262fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a4cedefd97648c256fa8f20ea3c4fa3 |
| publicationDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012030408-A1 |
| titleOfInvention |
Compounds and compositions for treating cancer |
| abstract |
The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331328-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10807977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11319316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758524-B2 |
| priorityDate |
2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |